Thomas P. Castellano
Net Worth

Last updated:

What is Thomas P. Castellano net worth?

The estimated net worth of Mr. Thomas P. Castellano is at least $3,693,260 as of 25 Aug 2022. He has earned $765,580 from insider trading and has received compensation worth at least $2,927,680 in Catalent, Inc..

What is the salary of Thomas P. Castellano?

Mr. Thomas P. Castellano salary is $731,920 per year as Senior Vice President & Chief Financial Officer in Catalent, Inc..

How old is Thomas P. Castellano?

Mr. Thomas P. Castellano is 45 years old, born in 1980.

What stocks does Thomas P. Castellano currently own?

As insider, Mr. Thomas P. Castellano owns shares in one company:

Company Title Shares Price per share Total value
Catalent, Inc. (CTLT) Senior Vice President & Chief Financial Officer 20,099 $0 $0

What does Catalent, Inc. do?

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.

Thomas P. Castellano insider trading

Catalent, Inc.

Mr. Thomas P. Castellano has made 5 insider trades between 2021-2022, according to the Form 4 filled with the SEC. Most recently he sold 1,414 units of CTLT stock worth $145,699 on 25 Aug 2022.

The largest trade he's ever made was exercising 2,307 units of CTLT stock on 20 Oct 2021. As of 25 Aug 2022 he still owns at least 20,099 units of CTLT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 1,414 $103.04 $145,699
Sale
Common Stock 347 $106.9 $37,094
Sale
Common Stock 2,307 $134 $309,138
Sale
Common Stock 2,093 $130.75 $273,649
Sale
Common Stock 555 N/A N/A

Catalent key executives

Catalent, Inc. executives and other stock owners filed with the SEC: